Physician profile
Barbara Simms
NPI 1184012874
$1,159.82
in general payments reported to CMS, 2019-2025
14 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $278 · 2022: $253 · 2023: $365 · 2024: $143 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $183.04 | 2021 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2023 | Xarelto |
| Lundbeck LLC | $124.99 | 2023 | Vyepti |
| Exelixis INC. | $124.97 | 2024 | Cabometyx |
| Pharmacyclics LLC, An Abbvie Company | $124.96 | 2022 | |
| Hologic Sales and Service, LLC | $121.27 | 2025 | Aptima |
| Mallinckrodt Hospital Products INC. | $115.23 | 2023 | Acthar |
| Novartis Pharmaceuticals Corporation | $90.77 | 2021-2022 | |
| Abbott Laboratories | $45.36 | 2022 | |
| Biogen, INC. | $30.98 | 2021-2022 | |
| Kci USA, INC. | $20.86 | 2022 | |
| Pfizer INC. | $18.24 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $17.25 | 2021 | |
| Lantheus Medical Imaging, INC. | $16.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Simms listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.